1
|
Herbst RS, Heymach JV and Lippman SM: Lung
cancer. N Engl J Med. 359:1367–1380. 2008. View Article : Google Scholar : PubMed/NCBI
|
2
|
Cheng TY, Cramb SM, Baade PD, Youlden DR,
Nwogu C and Reid ME: The international epidemiology of lung cancer:
Latest trends, disparities, and tumor characteristics. J Thorac
Oncol. 11:1653–1671. 2016. View Article : Google Scholar : PubMed/NCBI
|
3
|
Robinson BW, Musk AW and Lake RA:
Malignant mesothelioma. Lancet. 366:397–408. 2005. View Article : Google Scholar : PubMed/NCBI
|
4
|
Pistolesi M and Rusthoven J: Malignant
pleural mesothelioma: Update, current management, and newer
therapeutic strategies. Chest. 126:1318–1329. 2004. View Article : Google Scholar : PubMed/NCBI
|
5
|
Antman KH: Natural history and
epidemiology of malignant mesothelioma. Chest. 103:373S–376S. 1993.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Zhong J, Gencay MM, Bubendorf L, Burgess
JK, Parson H, Robinson BW, Tamm M, Black JL and Roth M: ERK1/2 and
p38 MAP kinase control MMP-2, MT1-MMP, and TIMP action and affect
cell migration: A comparison between mesothelioma and mesothelial
cells. J Cell Physiol. 207:540–552. 2006. View Article : Google Scholar : PubMed/NCBI
|
7
|
Chambers AF, Groom AC and MacDonald IC:
Dissemination and growth of cancer cells in metastatic sites. Nat
Rev Cancer. 2:563–572. 2002. View
Article : Google Scholar : PubMed/NCBI
|
8
|
Sahai E: Illuminating the metastatic
process. Nat Rev Cancer. 7:737–749. 2007. View Article : Google Scholar : PubMed/NCBI
|
9
|
Takata M, Maniwa Y, Doi T, Tanaka Y, Okada
K, Nishio W, Ohbayashi C, Yoshimura M, Hayashi Y and Okita Y:
Double-layered collagen gel hemisphere for cell invasion assay:
Successful visualization and quantification of cell invasion
activity. Cell Commun Adhes. 14:157–167. 2007. View Article : Google Scholar : PubMed/NCBI
|
10
|
Doi T, Maniwa Y, Tanaka Y, Tane S,
Hashimoto S, Ohno Y, Nishio W, Nishimura Y, Ohbayashi C, Okita Y,
et al: MT1-MMP plays an important role in an invasive activity of
malignant pleural mesothelioma cell. Exp Mol Pathol. 90:91–96.
2011. View Article : Google Scholar : PubMed/NCBI
|
11
|
Bolstad BM, Irizarry RA, Astrand M and
Speed TP: A comparison of normalization methods for high density
oligonucleotide array data based on variance and bias.
Bioinformatics. 19:185–193. 2003. View Article : Google Scholar : PubMed/NCBI
|
12
|
Gentleman RC, Carey VJ, Bates DM, Bolstad
B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, et al:
Bioconductor: Open software development for computational biology
and bioinformatics. Genome Biol. 5:R802004. View Article : Google Scholar : PubMed/NCBI
|
13
|
Quackenbush J: Microarray data
normalization and transformation. Nat Genet. 32:496–501. 2002.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Izumi H, Takahashi M, Uramoto H, Nakayama
Y, Oyama T, Wang KY, Sasaguri Y, Nishizawa S and Kohno K:
Monocarboxylate transporters 1 and 4 are involved in the invasion
activity of human lung cancer cells. Cancer Sci. 102:1007–1013.
2011. View Article : Google Scholar : PubMed/NCBI
|
15
|
Albini A, Iwamoto Y, Kleinman HK, Martin
GR, Aaronson SA, Kozlowski JM and McEwan RN: A rapid in vitro assay
for quantitating the invasive potential of tumor cells. Cancer Res.
47:3239–3245. 1987.PubMed/NCBI
|
16
|
Nyström ML, Thomas GJ, Stone M, Mackenzie
IC, Hart IR and Marshall JF: Development of a quantitative method
to analyse tumour cell invasion in organotypic culture. J Pathol.
205:468–475. 2005. View Article : Google Scholar : PubMed/NCBI
|
17
|
Duong HS, Le AD, Zhang Q and Messadi DV: A
novel 3-dimensional culture system as an in vitro model for
studying oral cancer cell invasion. Int J Exp Pathol. 86:365–374.
2005. View Article : Google Scholar : PubMed/NCBI
|
18
|
Kazi JU, Kabir NN and Rönnstrand L:
Brain-Expressed X-linked (BEX) proteins in human cancers. Biochim
Biophys Acta. 1856:226–233. 2015.PubMed/NCBI
|
19
|
Khazaei MR, Halfter H, Karimzadeh F, Koo
JH, Margolis FL and Young P: Bex1 is involved in the regeneration
of axons after injury. J Neurochem. 115:910–920. 2010. View Article : Google Scholar : PubMed/NCBI
|
20
|
Vilar M, Murillo-Carretero M, Mira H,
Magnusson K, Besset V and Ibáñez CF: Bex1, a novel interactor of
the p75 neurotrophin receptor, links neurotrophin signaling to the
cell cycle. EMBO J. 25:1219–1230. 2006. View Article : Google Scholar : PubMed/NCBI
|
21
|
Naderi A, Teschendorff AE, Beigel J,
Cariati M, Ellis IO, Brenton JD and Caldas C: BEX2 is overexpressed
in a subset of primary breast cancers and mediates nerve growth
factor/nuclear factor-kappaB inhibition of apoptosis in breast
cancer cell lines. Cancer Res. 67:6725–6736. 2007. View Article : Google Scholar : PubMed/NCBI
|
22
|
Naderi A, Liu J and Bennett IC: BEX2
regulates mitochondrial apoptosis and G1 cell cycle in breast
cancer. Int J Cancer. 126:1596–1610. 2010.PubMed/NCBI
|
23
|
de Ronde JJ, Lips EH, Mulder L, Vincent
AD, Wesseling J, Nieuwland M, Kerkhoven R, Vrancken Peeters MJ,
Sonke GS, Rodenhuis S, et al: SERPINA6, BEX1, AGTR1, SLC26A3, and
LAPTM4B are markers of resistance to neoadjuvant chemotherapy in
HER2-negative breast cancer. Breast Cancer Res Treat. 137:213–223.
2013. View Article : Google Scholar : PubMed/NCBI
|
24
|
Hofsli E, Wheeler TE, Langaas M, Laegreid
A and Thommesen L: Identification of novel neuroendocrine-specific
tumour genes. Br J Cancer. 99:1330–1339. 2008. View Article : Google Scholar : PubMed/NCBI
|
25
|
Foltz G, Ryu GY, Yoon JG, Nelson T, Fahey
J, Frakes A, Lee H, Field L, Zander K, Sibenaller Z, et al:
Genome-wide analysis of epigenetic silencing identifies BEX1 and
BEX2 as candidate tumor suppressor genes in malignant glioma.
Cancer Res. 66:6665–6674. 2006. View Article : Google Scholar : PubMed/NCBI
|
26
|
Karakoula K, Jacques TS, Phipps KP,
Harkness W, Thompson D, Harding BN, Darling JL and Warr TJ:
Epigenetic genome-wide analysis identifies BEX1 as a candidate
tumour suppressor gene in paediatric intracranial ependymoma.
Cancer Lett. 346:34–44. 2014. View Article : Google Scholar : PubMed/NCBI
|
27
|
Lindblad O, Li T, Su X, Sun J, Kabir NN,
Levander F, Zhao H, Lu G, Rönnstrand L and Kazi JU: BEX1 acts as a
tumor suppressor in acute myeloid leukemia. Oncotarget.
6:21395–21405. 2015. View Article : Google Scholar : PubMed/NCBI
|
28
|
Ding K, Su Y, Pang L, Lu Q, Wang Z, Zhang
S, Zheng S, Mao J and Zhu Y: Inhibition of apoptosis by
downregulation of hBex1, a novel mechanism, contributes to the
chemoresistance of Bcr/Abl+ leukemic cells.
Carcinogenesis. 30:35–42. 2009. View Article : Google Scholar : PubMed/NCBI
|
29
|
Xiao Q, Hu Y, Liu Y, Wang Z, Geng H, Hu L,
Xu D, Wang K, Zheng L, Zheng S, et al: BEX1 promotes
imatinib-induced apoptosis by binding to and antagonizing BCL-2.
PLoS One. 9:e917822014. View Article : Google Scholar : PubMed/NCBI
|
30
|
Che ZM, Jung TH, Choi JH, Yoon DJ, Jeong
HJ, Lee EJ and Kim J: Collagen-based co-culture for invasive study
on cancer cells-fibroblasts interaction. Biochem Biophys Res
Commun. 346:268–275. 2006. View Article : Google Scholar : PubMed/NCBI
|
31
|
Gaggioli C, Hooper S, Hidalgo-Carcedo C,
Grosse R, Marshall JF, Harrington K and Sahai E: Fibroblast-led
collective invasion of carcinoma cells with differing roles for
RhoGTPases in leading and following cells. Nat Cell Biol.
9:1392–1400. 2007. View Article : Google Scholar : PubMed/NCBI
|
32
|
Tane S, Maniwa Y, Hokka D, Tauchi S,
Nishio W, Okita Y and Yoshimura M: The role of Necl-5 in the
invasive activity of lung adenocarcinoma. Exp Mol Pathol.
94:330–335. 2013. View Article : Google Scholar : PubMed/NCBI
|
33
|
Friedl P and Wolf K: Tumour-cell invasion
and migration: Diversity and escape mechanisms. Nat Rev Cancer.
3:362–374. 2003. View Article : Google Scholar : PubMed/NCBI
|
34
|
Wolf K, Mazo I, Leung H, Engelke K, von
Andrian UH, Deryugina EI, Strongin AY, Bröcker EB and Friedl P:
Compensation mechanism in tumor cell migration:
Mesenchymal-amoeboid transition after blocking of pericellular
proteolysis. J Cell Biol. 160:267–277. 2003. View Article : Google Scholar : PubMed/NCBI
|
35
|
Friedl P and Alexander S: Cancer invasion
and the microenvironment: Plasticity and reciprocity. Cell.
147:992–1009. 2011. View Article : Google Scholar : PubMed/NCBI
|